Literature DB >> 16607518

[Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment].

G Lümmen1, T Jäger, F Sommer, T Ebert, B Schmitz-Draeger.   

Abstract

With improvements in cancer survival rates, more patients with cancer are living longer and the influence of nutrition, lifestyle, physical activity as well as supportive care during and after chemotherapy is of increasing interest. In several malignancies smoking cessation increases cancer survival. Similar effects are expected by healthy nutrition. Regular physical activity of cancer patients reduces drug interactions of chemotherapy, decreases the number of comorbid conditions, and helps patients maintain independence as long as possible. For supportive care during chemotherapy the 5-HT3 receptor antagonists are more effective for the prevention of chemotherapy-induced nausea and vomiting. There are several colony-stimulating factors (e.g. GCSF, erythropoietin) for hematopoietic recovery post-chemotherapy. Altogether supportive care of chemotherapy reduces toxicity and increases efficacy.

Entities:  

Mesh:

Year:  2006        PMID: 16607518     DOI: 10.1007/s00120-006-1037-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  103 in total

Review 1.  Does smoking status influence the prognosis of bladder cancer? A systematic review.

Authors:  P Aveyard; P Adab; K K Cheng; D M A Wallace; K Hey; M F G Murphy
Journal:  BJU Int       Date:  2002-08       Impact factor: 5.588

2.  The effect of aerobic exercise on patient reports of nausea.

Authors:  M L Winningham; M G MacVicar
Journal:  Oncol Nurs Forum       Date:  1988 Jul-Aug       Impact factor: 2.172

3.  Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer.

Authors:  Kazuo Nakamura; Hiroko Kariyazono; Teruo Komokata; Nobuo Hamada; Ryuzo Sakata; Katsushi Yamada
Journal:  Nutrition       Date:  2005-06       Impact factor: 4.008

4.  Paclitaxel premedication regimens.

Authors:  D K Boehm; A W Maksymiuk
Journal:  J Natl Cancer Inst       Date:  1996-04-03       Impact factor: 13.506

5.  Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.

Authors:  K D Heckman; G J Weiner; C S Davis; R G Strauss; M P Jones; C P Burns
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

6.  Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.

Authors:  S E Dunn; F W Kari; J French; J R Leininger; G Travlos; R Wilson; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

7.  Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.

Authors:  Shousong Cao; Farukh A Durrani; Youcef M Rustum
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

Review 8.  Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements?

Authors:  Mark A Moyad
Journal:  Curr Opin Urol       Date:  2003-09       Impact factor: 2.309

9.  Starting again--a comparison study of a group rehabilitation program for cancer patients.

Authors:  G Berglund; C Bolund; U L Gustavsson; P O Sjödén
Journal:  Acta Oncol       Date:  1993       Impact factor: 4.089

10.  Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.

Authors:  S D Hursting; S N Perkins; J M Phang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more
  1 in total

1.  Effects of nutritional and psychological status in gastrointestinal cancer patients on tolerance of treatment.

Authors:  Jun Tian; Zhen-Chun Chen; Li-Fang Hang
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.